Anthropic eyes antibiotic breakthrough ahead of IPO
Anthropic is set to reveal a novel antibiotic class targeting resistant bacteria ahead of its IPO, positioning the company at the intersection of AI and biotech. The analysis…
Topic
Drug discovery
Latest